Dongguan Hongyuan Yishi Biotechnology Pharmaceutical

Dongguan Hongyuan Yishi Biotechnology Pharmaceutical is a specialized biotechnology company headquartered in Dongguan, China, and operates as a key subsidiary of the Guangdong Hongyuan Group. The company focuses on the research, development, and clinical application of regenerative medicine, specifically targeting stem cell and immune cell technologies. It maintains a large-scale, state-of-the-art cell bank that provides professional storage services for umbilical cord blood, adipose-derived stem cells, and immune cells. Beyond storage, the firm is actively involved in developing cell-based solutions for anti-aging, chronic disease management, and immune system optimization. Their facilities include GMP-compliant laboratories designed for high-standard biological research and production. The company aims to bridge the gap between basic cell research and clinical health management.